[1]雷 伟,曾雅彬,吴淑睿.内镜辅助下不同手术方法治疗复发性泪囊炎患者远期效果及并发症对比研究[J].医学信息,2026,39(10):99-103.[doi:10.3969/j.issn.1006-1959.2026.10.016]
　LEI Wei,ZENG Yabin,WU Shurui.A Comparative Study on the Long-term Effects and Complications of Different Surgical MethodsUnder Endoscopic-assisted Treatment for Patients with Recurrent Dacryocystitis[J].Journal of Medical Information,2026,39(10):99-103.[doi:10.3969/j.issn.1006-1959.2026.10.016]
点击复制

内镜辅助下不同手术方法治疗复发性泪囊炎患者远期效果及并发症对比研究()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
39卷
期数:
2026年10期
页码:
99-103
栏目:
临床证据信息
出版日期:
2026-05-15

文章信息/Info

Title:
A Comparative Study on the Long-term Effects and Complications of Different Surgical MethodsUnder Endoscopic-assisted Treatment for Patients with Recurrent Dacryocystitis
文章编号:
1006-1959（2026）10-0099-05
作者:
雷 伟; 曾雅彬; 吴淑睿
会昌县人民医院眼耳鼻喉科，江西 会昌 342600
Author(s):
LEI Wei;  ZENG Yabin;  WU Shurui
Department of Ophthalmology and Otorhinolaryngology, Huichang County People′s Hospital, Huichang 342600, Jiangxi, China
关键词:
鼻内镜鼻腔泪囊吻合术; 鼻内镜经鼻泪总管开放术; 复发性泪囊炎; 远期效果
Keywords:
Endoscopic dacryocystorhinostomy;  Endoscopic transnasolacrimal duct opening;  Recurrent dacryocystitis;  Long-term effect
分类号:
R777.2+3
DOI:
10.3969/j.issn.1006-1959.2026.10.016
文献标志码:
A
摘要:
目的 对比鼻内镜鼻腔泪囊吻合术、鼻内镜经鼻泪总管开放术治疗复发性泪囊炎的远期效果及并发症。方法 选取2023年1月-2024年6月在会昌县人民医院治疗的76例复发性泪囊炎患者，按照随机数字表法将其分为A、B两组，各38例。A组采用鼻内镜鼻腔泪囊吻合术，B组采用鼻内镜经鼻泪总管开放术。比较两组手术相关指标（手术时间、术中出血量、住院时间、住院费用）、临床疗效、溢泪症状评分、术后造瘘口面积、并发症发生率（鼻黏膜损伤、鼻腔出血、造瘘口堵塞、感染）。结果 A组手术时间、住院时间短于B组，术中出血量少于B组，住院费用低于B组（P＜0.05）；与B组治疗总有效率的71.05%相比，A组更高，达94.74%（P＜0.05）；术后3个月，两组溢泪症状评分均低于术前，且A组低于B组（P＜0.05）；术后1、3、6个月，A组造瘘口面积均大于B组（P＜0.05）；与B组并发症发生率的23.68%相比，A组更低，仅为5.26%（P＜0.05）。结论 鼻内镜鼻腔泪囊吻合术治疗复发性泪囊炎的临床效果良好，可有效改善患者症状，促进造瘘口愈合，降低并发症发生风险，加快术后康复进程。
Abstract:
Objective To compare the long-term efficacy and complications of endoscopic dacryocystorhinostomy versus endoscopic transnasolacrimal duct opening in the treatment of recurrent dacryocystitis. Methods A total of 76 patients with recurrent dacryocystitis treated at Huichang County People′s Hospital from January 2023 to June 2024 were selected and randomly divided into two groups (group A and group B) using a random number table, with 38 patients in each group. Group A underwent endoscopic dacryocystorhinostomy, while group B received endoscopic transnasolacrimal duct opening. The two groups were compared in terms of surgery-related indicators (operation time, intraoperative blood loss, length of hospital stay, and hospitalization costs), clinical efficacy, epiphora symptom score, postoperative fistula area, and incidence of complications (nasal mucosal injury, nasal hemorrhage, stoma occlusion, and infection). Results The operation time and hospitalization time of group A were shorter than those of group B, the intraoperative blood loss was less than that of group B, and the hospitalization cost was lower than that of group B (P<0.05). The total clinical efficacy rate in group A was 94.74%, which was significantly higher than the 71.05% observed in group B (P<0.05). At 3 months after operation, the score of epiphora symptoms in both groups was lower than that before operation, and that in group A was lower than that in group B (P<0.05). At 1, 3 and 6 months after operation, the area of stoma in group A was larger than that in group B (P<0.05). Compared with the incidence of complications in group B (23.68%), the incidence of complications in group A was lower, only 5.26% (P<0.05). Conclusion Endoscopy dacryocystorhinostomy demonstrates favorable clinical efficacy in the treatment of recurrent dacryocystitis. It effectively alleviates patient symptoms, promotes fistula healing, reduces the risk of complications, and accelerates the postoperative recovery process.

参考文献/References:

[1]赵璐,申文婷,张明红,等.鼻内镜下泪总管暴露治疗小泪囊慢性泪囊炎的临床分析[J].临床眼科杂志,2022,30(1):54-57.[2]杜安杰,孙松林,翟俊涛.鼻内镜下泪囊鼻腔吻合术治疗二种慢性泪囊炎的疗效分析[J].安徽医药,2023,27(4):801-803.[3]毛帮汛,杨陈,吴文灿,等.内镜下泪囊鼻腔吻合术治疗急性泪囊炎急性发作期的疗效[J].中国内镜杂志,2023,29(7):83-88.[4]杨平孙,陈卫兵.经鼻内窥镜下扩展性骨窗伴高位造口行泪囊鼻腔吻合术治疗慢性泪囊炎[J].国际眼科杂志,2023,23(5):860-863.[5]吴智文,吴战斌,孙松林.单纯鼻内镜下泪囊鼻腔吻合术与联合泪小管置管术治疗慢性泪囊炎的临床疗效对比[J].中国中医眼科杂志,2024,34(6):530-533.[6]王红霞,聂冬丽,姜敏,等.鼻内窥镜下鼻腔泪囊吻合术治疗慢性泪囊炎疗效及治疗满意度临床观察[J].解放军医药杂志,2021,33(6):88-91.[7]张丹,罗荣莹,钟兵,等.鼻内镜下泪囊鼻腔造孔术与鼻外路径鼻腔泪囊吻合术治疗复发性泪囊炎疗效对比[J].西部医学,2020,32(9):1371-1375.[8]王媛,马晓琳,周传海,等.鼻内镜下内囊鼻腔吻合术联合泪道扩张引流管治疗泪囊炎合并泪道阻塞:120例患者随机对照试验[J].分子影像学杂志,2021,44(5):771-775.[9]刘大英,王宗杰,裴喜玲,等.鼻内镜下经鼻高位泪囊鼻腔吻合术治疗慢性泪囊炎的临床观察[J].中国耳鼻咽喉头颈外科,2021,28(9):577-578.[10]郑璇,李军政.尖吻蝮蛇凝酶对慢性泪囊炎患者经鼻内窥镜下泪囊鼻腔吻合术的有效性和安全性[J].血栓与止血学,2021,27(5):839-840.[11]张文彬,丁芝祥,廖妙云,等.经鼻内窥镜下鼻腔泪囊吻合术治疗泪囊炎疗效的影响因素分析[J].国际眼科杂志,2020,20(9):1637-1640.[12]谷瑞东,孙凯健,肖凡,等.经鼻内窥镜下泪囊鼻腔吻合术治疗慢性泪囊炎386例疗效观察[J].大连医科大学学报,2020,42(2):150-153,165.[13]王松,许育新,陶黎明.泪道硅胶引流管植入术与鼻内窥镜下鼻腔泪囊吻合术治疗慢性泪囊炎的疗效对比[J].安徽医药,2020,24(5):963-965.[14]梁坤,蒋正轩,许育新,等.鼻内镜下去除鼻黏膜瓣泪囊鼻腔吻合术治疗慢性泪囊炎的疗效观察[J].临床眼科杂志,2019,27(3):260-262.[15]赵玮.高位泪囊鼻腔吻合术治疗小泪囊型慢性泪囊炎的临床疗效观察[J].中国耳鼻咽喉头颈外科,2022,29(10):669-670.[16]步建平,王晶.经眼光导纤维引导鼻内镜下鼻腔泪囊吻合术治疗人工鼻泪管支架植入术后复发性泪囊炎的疗效观察[J].医学综述,2019,25(12):2488-2491.[17]高先新,吴承定.经鼻内窥镜泪囊鼻腔吻合术治疗慢性泪囊炎的学习曲线探讨[J].中华保健医学杂志,2019,21(5):461-462.[18]常涛,吴丹丹,金建平,等.微瓣缝合法在鼻内镜下泪囊鼻腔吻合术中的应用[J].中国眼耳鼻喉科杂志,2023,23(6):484-487.[19]赵俊华,周国宏,王永瑞.鼻内镜下鼻腔泪囊吻合术115例临床观察[J].山西医药杂志,2020,49(15):2027-2028.[20]张守凯,梁丹茹,刘勤.不同术式治疗60例慢性泪囊炎的临床疗效比较[J].中国中医眼科杂志,2019,29(4):311-317.

更新日期/Last Update: 1900-01-01